EMTN programme update - publication of Prospectus
25 May 2021 07:00 BST EMTN programme update: publication of Prospectus Following an update by AstraZeneca PLC ("AstraZeneca") of its Euro Medium Term Note ("EMTN") programme established in 2007, the following prospectus has been approved by the Financial Conduct Authority and is available for viewing: Base Prospectus for the AstraZeneca and AstraZeneca Finance LLC U.S. $10,000,000,000 Euro Medium Term Note Programme (the "Prospectus"). AstraZeneca Finance LLC has been added as an issuer to the EMTN programme for 2021. Securities under the programme may therefore be issued by